Ping Zhao1, Benshu Zhang, Shuo Gao. 1. Department of Neurology, Second Hospital of Tianjin Medical University, Tianjin, China.
Abstract
OBJECTIVE: To investigate the difference in glucose metabolism on (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG PET) imaging for differential diagnosis of idiopathic Parkinson's disease (IPD) from several parkinsonian-plus syndromes using SPM2 approach. METHODS: (18)F-FDG PET was performed for 18 IPD patients, 22 multiple system atrophy (MSA) patients, 13 progressive supranuclear palsy (PSP) patients, 5 corticobasal degeneration (CBD) patients, 7 dementia with Lewy bodies (DLB) patients and 1 normal pressure hydrocephalus (NPH) patient. Imaging-based diagnosis was obtained by statistical parametric mapping (SPM2) software to analyze the differences and overlaps among these groups. RESULTS: The (18)F-FDG PET images analyzed with SPM2 demonstrated that a reduction in glucose metabolism occurred in bilateral parietal area for IPD, in bilateral putamen for MSA-P, in bilateral cerebellum for MSA-C, in midbrain and the middle frontal cortex for PSP, in asymmetrical metabolism of the cortex and the basal ganglia for CBD, in bilateral occipital and parieto-occipital areas for DLB. The metabolic reductions in a patient of NPH group were observed in the ventricular system. CONCLUSIONS: This study identifies different patterns of glucose metabolism in parkinsonism. (18)F-FDG PET imaging may contribute to early differential diagnosis in clinically ambiguous cases of parkinsonism.
OBJECTIVE: To investigate the difference in glucose metabolism on (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG PET) imaging for differential diagnosis of idiopathic Parkinson's disease (IPD) from several parkinsonian-plus syndromes using SPM2 approach. METHODS: (18)F-FDG PET was performed for 18 IPD patients, 22 multiple system atrophy (MSA) patients, 13 progressive supranuclear palsy (PSP) patients, 5 corticobasal degeneration (CBD) patients, 7 dementia with Lewy bodies (DLB) patients and 1 normal pressure hydrocephalus (NPH) patient. Imaging-based diagnosis was obtained by statistical parametric mapping (SPM2) software to analyze the differences and overlaps among these groups. RESULTS: The (18)F-FDG PET images analyzed with SPM2 demonstrated that a reduction in glucose metabolism occurred in bilateral parietal area for IPD, in bilateral putamen for MSA-P, in bilateral cerebellum for MSA-C, in midbrain and the middle frontal cortex for PSP, in asymmetrical metabolism of the cortex and the basal ganglia for CBD, in bilateral occipital and parieto-occipital areas for DLB. The metabolic reductions in a patient of NPH group were observed in the ventricular system. CONCLUSIONS: This study identifies different patterns of glucose metabolism in parkinsonism. (18)F-FDG PET imaging may contribute to early differential diagnosis in clinically ambiguous cases of parkinsonism.
Authors: Shinsuke Fujioka; Bradley F Boeve; Joseph E Parisi; Pawel Tacik; Naoya Aoki; Audrey J Strongosky; Matt Baker; Monica Sanchez-Contreras; Owen A Ross; Rosa Rademakers; Vesna Sossi; Dennis W Dickson; A Jon Stoessl; Zbigniew K Wszolek Journal: Parkinsonism Relat Disord Date: 2014-08-19 Impact factor: 4.891
Authors: Nicholas Zalewski; Hugo Botha; Jennifer L Whitwell; Val Lowe; Dennis W Dickson; Keith A Josephs Journal: J Neurol Date: 2014-02-04 Impact factor: 4.849
Authors: Martin Niethammer; Chris C Tang; Andrew Feigin; Patricia J Allen; Lisette Heinen; Sabine Hellwig; Florian Amtage; Era Hanspal; Jean Paul Vonsattel; Kathleen L Poston; Philipp T Meyer; Klaus L Leenders; David Eidelberg Journal: Brain Date: 2014-09-09 Impact factor: 13.501
Authors: Stephen M Broski; Christopher H Hunt; Geoffrey B Johnson; Robert F Morreale; Val J Lowe; Patrick J Peller Journal: Radiographics Date: 2014 Sep-Oct Impact factor: 5.333